| Determinants of immune response to anti–SARS-CoV-2 mRNA vaccines in kidney transplant recipients: a prospective cohort study M Magicova, I Zahradka, M Fialova, T Neskudla, J Gurka, I Modos, ... Transplantation 106 (4), 842-852, 2022 | 26 | 2022 |
| Humoral response to SARS-CoV-2 is well preserved and symptom dependent in kidney transplant recipients M Magicova, M Fialova, I Zahradka, S Rajnochova-Bloudickova, ... American Journal of Transplantation 21 (12), 3926-3935, 2021 | 16 | 2021 |
| Association between SARS-CoV-2 messenger RNA vaccines and lower infection rates in kidney transplant recipients: a registry-based report I Zahradka, V Petr, I Modos, M Magicova, L Dusek, O Viklicky Annals of Internal Medicine 175 (7), 961-968, 2022 | 9 | 2022 |
| The impact of frailty syndrome on humoral response to SARS-CoV-2 mRNA vaccines in older kidney transplant recipients M Schmalz, H Vankova, S Rajnochova-Bloudickova, P Hruba, M Fialova, ... International Urology and Nephrology 55 (11), 2959-2965, 2023 | 2 | 2023 |
| Novel transcriptomic signatures associated with premature kidney allograft failure P Hruba, J Klema, AV Le, E Girmanova, P Mrazova, A Massart, ... EBioMedicine 96, 2023 | 2 | 2023 |
| Early referring saved lives in kidney transplant recipients with COVID-19: a beneficial role of telemedicine I Zahradka, V Petr, K Jakubov, I Modos, F Hruby, O Viklicky Frontiers in Medicine 10, 1252822, 2023 | 2 | 2023 |
| First booster of SARS-COV-2 mRNA vaccine is not associated with alloimmunization and subclinical injury of kidney allograft V Petr, I Zahradka, I Modos, M Roder, A Prewett, M Fialova, J Machkova, ... Transplantation 107 (2), e62-e64, 2023 | 2 | 2023 |
| SARS-CoV-2 mRNA vaccination is not associated with the risk of allosensitization in patients awaiting kidney transplantation I Zahradka, V Petr, I Modos, K Kabrtova, A Slavcev, O Viklicky Transplantation 106 (12), e522-e524, 2022 | 2 | 2022 |
| Tacrolimus after rATG and infliximab induction immunosuppression—RIMINI trial O Viklicky, I Zahradka, G Bold, O Bestard, P Hruba, NM Otto, M Stein, ... Transplantation 108 (1), 242-251, 2024 | 1 | 2024 |
| Background risk should be taken into account when reporting vaccine effectiveness I Zahradka, V Petr, M Magicova, O Viklicky American Journal of Transplantation 22 (7), 1927-1928, 2022 | 1 | 2022 |
| MP175ATYPICAL HEMOLYTIC UREMIC SYNDROME-VERY EARLY TREATMENT IS A WAY TO SUCCESS? V Petr, I Zahradka, K Kratka, M Grussmannova, E Honsova, I Rychlik Nephrology Dialysis Transplantation 32 (3), iii492-iii492, 2017 | 1 | 2017 |
| Attenuated Neutralization, Maintained Specificity: Humoral Response to SARS-CoV-2 Booster in Kidney Allograft Recipients M Fialova, E Cecrdlova, I Zahradka, V Petr, F Hruby, I Modos, O Viklicky, ... Diagnostic Microbiology and Infectious Disease, 116550, 2024 | | 2024 |
| Safety and Immunogenicity of SARS-CoV-2 mRNA Vaccine Booster Doses in Kidney Transplant Recipients: Results of a 12-mo Follow-up From a Prospective Observational Study V Petr, I Zahradka, I Modos, M Roder, M Fialova, J Machkova, K Kabrtova, ... Transplantation Direct 10 (6), e1645, 2024 | | 2024 |
| Calcineurin inhibitor toxicity in de novo thrombotic microangiopathy—Is the culprit what we think it is? V Petr, I Zahradka, O Viklicky American Journal of Transplantation, 2024 | | 2024 |
| Morning administration enhances humoral response to SARS-CoV-2 vaccination in kidney transplant recipients I Zahradka, F Tichanek, M Magicova, I Modos, O Viklicky, V Petr American Journal of Transplantation, 2024 | | 2024 |
| Co je nového v nefrologii? I Zahrádka, O Viklický Vnitřní lékařství 69 (8), 534-541, 2023 | | 2023 |
| The Impact of Frailty Syndrome on Humoral Response to SARS-CoV-2 mRNA Vaccines in Older Kidney Transplant Recipients. M Schmalz, H Vankova, S Rajnochova-Bloudickova, P Hruba, M Fialova, ... AMERICAN JOURNAL OF TRANSPLANTATION 22, 647-647, 2022 | | 2022 |
| Tacrolimus After Rabbit Antithymocyte Globulin and Infliximab Induction Immunosuppression in Kidney Transplantation O Viklicky, G Bold, O Bestard, P Hruba, I Zahradka, NM Otto, M Stein, ... AMERICAN JOURNAL OF TRANSPLANTATION 22, 595-596, 2022 | | 2022 |
| SARS-CoV-2 IgG seroprevalence and factors affecting its levels in kidney transplant recipients during second peak of covid-19 pandemic M Magicova, I Zahradka, M Fialova, T Neskudla, P Smejkal, I Striz, ... TRANSPLANT INTERNATIONAL 34, 269-269, 2021 | | 2021 |
| Is There a Treatment Difference of Mineral Bone Disease Among Survivals Versus Non-Survivals in Chronic Dialysis Patient (National-Wide Study)? L Francova, A Hybsova, I Zahradka, SD Sulkova, S Opatrna, V Tesar, ... NEPHROLOGY DIALYSIS TRANSPLANTATION 32, 685-685, 2017 | | 2017 |
Prof. Ondrej ViklickyInstitute for Clinical and Experimental Medicine在 ikem.cz 的电子邮件经过验证
